Mutations in PIK3CA, part of the gene for PI3K, have been identified in up to 36% of hepatocellular carcinoma, 26% of breast cancer and 26% of colon cancer [14,15]. This evidence concerns the gene PIK3CA and hepatocellular carcinoma.